New voter surge in early voting could sway battleground states in 2024 US presidential election    Civil Defense urges caution amid forecast of heavy rain to hit most Saudi regions until Monday    What's in it for FinTech startups in events like Biban24    Al Nassr and Al Hilal share points in intense Riyadh Derby draw    ImpaQ: Riyadh to host first Impact Makers Forum in December    Saudi Arabia ranks 12th globally in international visitor spending in 2023    SFDA chief discusses investment opportunities in food and pharmaceutical sectors with Chinese companies    Riyadh's Sports Boulevard receives Platinum ActiveScore certifications    Saudi Arabia refutes claims of rising worker fatalities, highlighting low work-related death rates    US says around 8,000 troops from North Korea are stationed in Russia's Kursk region    Spain mourns as death toll passes 150 in catastrophic floods    Seven killed in Israel in deadliest Hezbollah rocket strikes in months    Cyclists on phones face jail under Japan's new traffic laws    Hidden sugars in Asia's baby food spark concerns    Saleh Al Shehri strike seals Al Ittihad's Sea Derby win over Al Ahli    HONOR unveils pre-order of the stunning HONOR MagicBook Art 14 Featuring an ultra-slim design, HONOR Eye Comfort Display and AI Cross-OS WorkStation    Derby Week makes its debut in the Roshn Saudi League    Al Nassr eliminated from King's Cup after a defeat to Al Taawoun    Teri Garr, Young Frankenstein and Tootsie star, dies at 79    Indonesia Days event celebrates cultural diversity at Al Suwaidi Park    India puts blockbuster Pakistani film on hold    The Vikings and the Islamic world    Filipino pilgrim's incredible evolution from an enemy of Islam to its staunch advocate    Muted Eid celebrations for millions of Nigerian Muslims    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



European regulator 'convinced' benefits of AstraZeneca COVID-19 vaccine outweigh risks
Published in The Saudi Gazette on 17 - 03 - 2021

Europe's medicines regulator has said there's "no indication" that the Oxford-AstraZeneca COVID-19 vaccine has caused blood clots, as the list of countries temporarily halting the vaccine's rollout over safety concerns continues to grow.
On Tuesday, Cyprus, Luxembourg, Latvia, and Sweden became the latest European nations to suspend its use, despite advice from the European Medical Authority (EMA) and other international medical agencies that the benefits of getting shots into arms outweigh any potential risks.
The head of the EMA, which authorized the use of the Oxford-AstraZeneca vaccine for the 27-nation bloc, said Tuesday that regulators remained "firmly convinced" of that assessment.
"At present, there is no indication that vaccination has caused these conditions, they have not come up in the clinical trials and they are not listed as known or expected side events with this vaccine," its executive director Emer Cooke told a digital press conference Tuesday.
"We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing Covid-19, with its associated risk of hospitalization and death, outweigh these side effects," Cooke said, adding that she was concerned the suspensions would damage confidence in the vaccines.
The EMA's safety committee is investigating whether there is any possible link between the Oxford-AstraZeneca vaccine and a small number of blood clots in vaccinated people. It is slated to release its findings during an extraordinary meeting called by the agency on Thursday.
The World Health Organization's vaccine safety experts were due to meet Tuesday to discuss the Oxford-AstraZeneca vaccine, a day after the UN health agency appealed to countries to keep up vaccination campaigns while investigations are ongoing.
"As of today, there is no evidence that the incidents are caused by the vaccine and it is important that vaccination campaigns continue so that we can save lives and stem severe disease from the virus," WHO spokesman Christian Lindmeier said.
WHO is assessing the latest reports of thromboembolic events, but said it was "unlikely" to change its recommendations.
But much of Europe has gone against the EMA and WHO's advice in recent days, temporarily halting AstraZeneca shots even as the continent confronts a third wave of the pandemic, spurred by variants of the virus, and faces criticism over sluggish vaccination campaigns.
Those decisions were coordinated in France, Italy, Spain, and Germany, the French industry minister Agnès Pannier-Runacher said on Tuesday. "As you can imagine, we spoke. We spoke with Italy, we spoke with Spain, we spoke with Germany and it is no coincidence that these four countries announced the same decision on the same day, which once again is a decision of suspension," Pannier-Runacher told French radio station France info.
AstraZeneca isn't the only vaccine available in Europe. The EU has also authorized the BioNTech-Pfizer, Moderna and Johnson & Johnson vaccines. Doses of the BioNTech-Pfizer and Moderna vaccines are currently being rolled out to Europeans, but the first deliveries of the Johnson & Johnson vaccine aren't expected to arrive until mid-April. On Tuesday, Pfizer agreed to accelerate delivery of 10 million doses of its COVID-19 vaccine to the EU, days after AstraZeneca said it would have a "shortfall" in planned vaccine shipments to the bloc.
The AstraZeneca vaccine, which has been authorized for use in dozens of countries globally, has not yet been given the green light by regulators in the United States.
The EMA is looking into blood clot reports related to the BioNTech-Pfizer and Moderna vaccines too, Cooke said Tuesday. She said it was unlikely that there would be a potential issue with one specific AstraZeneca batch, but confirmed that the final outcome of the agency's review is set to come on Thursday.
Denmark was the first to press pause on the AstraZeneca vaccine last Thursday as a "precautionary measure" while Danish health officials investigate potential side effects after one person who developed a blood clot after vaccination died. Norway, Iceland, and Bulgaria quickly followed suit.
The Danish woman who died after vaccination had a low number of platelets, blood clots in small and large vessels and bleeding, according to the Danish Medicines Agency.
"The clinical picture is highly unusual and is currently being thoroughly investigated by the European Medicines Agency," the agency said in a statement on Monday.
Another death was reported in Norway on Monday, along with a handful of non-fatal cases with similar "unusual" adverse reactions, the Norwegian Medicines Agency said. The agency has received over 1,000 reports of side effects in recent days, which it said it is currently reviewing.
AstraZeneca, meanwhile, has doubled down on the safety of its vaccine. In a statement on Sunday, the pharmaceutical giant said that of the 17 million people vaccinated in the European Union and the United Kingdom so far, blood clot incidents were "much lower than would be expected to occur naturally in a general population."
Still, Spain, Germany, France, Italy, Portugal, Ireland, the Netherlands and Indonesia have joined countries halting AstraZeneca vaccinations.
Most countries to issue a suspension of the vaccine have acknowledged there is no evidence yet that the AstraZeneca shots had caused the blood clots.
The AstraZeneca vaccine, which was authorized for use by the WHO in February, is seen as key to fighting the coronavirus in lower- and middle-income countries because it is cheap and easy to store.
Those two factors have made it a lynchpin for rollout plans globally. And fears are growing that the handling of blood clot reports will impact vaccine confidence.
The European Union's Commissioner for Health Stella Kyriakides on Tuesday urged countries to use all their vaccine doses.
"The rollout of the vaccination is more than ever key in order to decrease the number of infected people," Kyriakides said.
She nodded to the tensions between AstraZeneca and the EU over the pharmaceutical company's failure to deliver as many doses as contracted but said countries should push ahead with inoculations.
"We recognize the significant and regrettable challenges around production and deliveries, but we do however urge member states to use all the available doses as we are currently seeing the proportions of available doses used range from 50 to 100 percent to across member states," Kyriakides added. "Every dose counts and every dose is providing a protective shield for health workers, for the most vulnerable groups, for the elderly."
EU and associated countries are sitting on nearly 8 million unused doses of the AstraZeneca vaccine, European Centre for Disease Control and Prevention data showed as of Monday.
The chief investigator on the Oxford-AstraZeneca vaccine trial, Andrew Pollard, warned it was "absolutely critical" people weren't put off from receiving the vaccination as countries in Europe see the third surge in infections. He said it appears from the data received from regulators there was "no signal of a problem."
"It's absolutely critical that there is careful evaluation of these cases, they've obviously been flagged in a couple of countries around Europe, so they need to be looked at very closely to see if there's anything unusual about them ... but in the meantime, we really need to make sure that people are protected against COVID-19," Pollard said in an interview on BBC Radio 4's Today program.
Britain's medicines regulator on Monday said it had not seen any uptick in blood clots in the UK, where more than 11 million doses of AstraZeneca have been administered.
The UK, where the Oxford-AstraZeneca vaccine was developed and is being manufactured, is among a number of countries that are still sticking with the shot. Belgium, Australia, Poland, Nigeria, Mexico and the Philippines have said they will continue to use the vaccine as investigations progress.
After becoming the first country outside Europe to delay its rollout of the Oxford-AstraZeneca vaccine, Thailand said on Monday that it would continue to receive doses.
Thailand's Prime Minister Prayut Chan-o-cha and members of his cabinet received their first shots of the vaccine on Tuesday, broadcast in a live stream.
"This will build confidence among the general public to receive vaccinations arranged by the government," Prayut said after the inoculation. — Courtesy CNN


Clic here to read the story from its source.